An important goal for Diabeter is to optimize the outcome for every patient, and minimize the burden of the disease. Our use of an electronic disease management system (VCare) for over 15 years means that we have collected a vast amount of data, as well as experience. Rigorous scientific analyses of our datasets makes it possible for us to identify factors associated with better outcomes, and improve the care that we deliver.
Diabeter is also actively involved in clinical trials and other research, contributing to the continual improvement in diabetes care that has occurred in recent years: these include advances in continuous glucose measurement, new insulin delivery systems and other devices, and new therapeutic options such as very short-acting or very long-acting insulins.
As these new medicines and new technologies enter the real world, we can make use of the VCare system to continually evaluate their impact on the management of T1DM. We can provide useful data on usability, efficacy, safety, and cost-effectiveness.
Our work in the field of outcomes research has included:
Through research such as this, we can help refine and optimize treatment and its outcomes, developing the most appropriate personalized care for each patient.